Innovations in Immunology: Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines

September 3, 2019

Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug resistance is a constant threat. Effective vaccines are urgently required and would add substantially to the ongoing efforts to curb these diseases.

The first vaccine against malaria to receive a positive opinion from the European Medicines Agency will soon be tested in implementation trials in three African countries: Kenya, Malawi and Ghana.

Read the full article here

More News

The British Immunological Society launches the “Celebrate Vaccines” campaign on March 26

March 25, 2020

CALL FOR EXPERTS: IUIS-Frontiers in Immunology Webinar Series on COVID-19

March 13, 2020

Modified tuberculosis vaccine as therapy against bladder cancer

March 5, 2020

ASI Invite IUIS Members to Become a Member

February 26, 2020Australian and New Zealand Society for Immunology

Coronavirus disease (COVID-19)

February 24, 2020

Early Career Research Prize in Vaccinology R&D – Call for Applications!

February 10, 2020

IUIS-FAIS-SAI-AAA Immuno Algeria 2020: Challenge of Allergy in the molecular era

January 31, 2020

Congratulations to winners of the GECD Travel Award 2020

January 10, 2020

IUIS-AAI travel fellowships 2020

December 16, 2019Gender Equality and Career Development Committee (GEC), Education Committee (EDU)